Evidence map›Paper›PMID 29740400›Full record

ArticleFrontiers in endocrinology2018

The Role of

Heta Huttunen, Matti Hero, Mitja Lääperi, Johanna Känsäkoski, Heikki Swan, Joel A Hirsch, Päivi J Miettinen, Taneli Raivio

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Heta HuttunenDepartment of Physiology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Matti HeroChildren's Hospital, Pediatric Research Center, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.
Mitja LääperiDepartment of Physiology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Johanna KänsäkoskiDepartment of Physiology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Heikki SwanHeart and Lung Center, Helsinki University Hospital, Helsinki, Finland.
Joel A HirschDepartment of Biochemistry and Molecular Biology, George S. Wise Faculty of Life Sciences, Institute of Structural Biology, Tel Aviv University, Ramat Aviv, Israel.
Päivi J MiettinenChildren's Hospital, Pediatric Research Center, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.
Taneli RaivioDepartment of Physiology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
University of Helsinki · FIHelsinki University Hospital · FITel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTwo missense mutations in

designMedical records of 104 patients with LQT1 in a single tertiary care center between 1995 and 2015 were retrospectively reviewed.

methodsClinical and endocrine data of the LQT1 patients were included in the analyses.

resultsAt birth, patients with a maternally inherited mutation (

conclusionLoss-of-function mutations in

Indexed as

beta blockergrowthion channelsKCNQ1long QT syndrome 1

Identifiers

PMID29740400
PMCPMC5928157
OpenAlexW2799686033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.